Lexaria Bioscience LEXX
NASDAQ LEXX
$2.83 +0.17 (+6.65%)
As of: Oct 21, 2026 · 1:03 PM EDT

Lexaria Bioscience (LEXX) Non-Current Debt (2011 - 2020)

Updated

Lexaria Bioscience (LEXX) posted Non-Current Debt of -$50,000 for FY2017 (year ended Aug 31, 2017), compared with $95,000 in FY2016.

Analysis

Lexaria Bioscience (LEXX) Non-Current Debt (2011 - 2020) Analysis & Trends

Since FY2010, Lexaria Bioscience has reported Non-Current Debt for 7 fiscal years.

  • Annual Non-Current Debt has run from a low of -$365,359 in FY2013 to a high of $95,000 in FY2016 over five years.
  • Business Quant data shows LEXX's Non-Current Debt at $95,000 in FY2016, -$98,742 in FY2015, -$306,893 in FY2014 and -$365,359 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 62.48 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 60.50 Bn
10 Lexaria Bioscience 2.62 Mn -12.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 30,852.00
Aug 31, 2020 30,670.00
May 31, 2020 28,756.00
Oct 31, 2011 599,438.00
API Access

Lexaria Bioscience Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LEXX&period=max&api_key=YOUR_API_KEY